Fig. 3.

The survival analysis of allocated patient is shown (n=33). The probability of avoiding relapse (AR) (% AR) following a series of 10 weekly granulocyte/monocyte adsorption treatments tended to be higher in the True group at the primary end-point compared with the other two arms. However, a log-rank test did not reveal a statistically significant difference between the True group and the other two groups (p=0.2641). In addition, the Kaplan-Meier survival analysis did not indicate a significant difference between the True and Sham groups (p=0.1297) or between the True and Control groups (p=0.4240).